Tianjin Lisheng Pharmaceutical Co., Ltd. logo

Tianjin Lisheng Pharmaceutical Co., Ltd. (002393)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
14. 79
-0.1
-0.6716%
¥
5.31B Market Cap
- P/E Ratio
1.4% Div Yield
2.86M Volume
- Eps
¥ 14.89
Previous Close
Add Transaction
Day Range
14.73 14.99
Year Range
13.37 22.25
Want to track 002393 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002393 closed today lower at ¥14.79, a decrease of -0.6716% from yesterday's close, completing a monthly increase of 4.2283% or ¥0.6. Over the past 12 months, 002393 stock lost -31.8433%.
002393 pays dividends to its shareholders, with the most recent payment made on Apr 28, 2026. The next estimated payment will be in 2 weeks ago on Jul 28, 2026 for a total of ¥0.72.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.2157%. On average, the company has surpassed earnings expectations by 0.27%, based on the last three reports.
Tianjin Lisheng Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Apr 28, 2026.
The company's stock is traded on one exchange.

002393 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Tianjin Lisheng Pharmaceutical Co., Ltd. (002393) FAQ

What is the stock price today?

The current price is ¥14.79.

On which exchange is it traded?

Tianjin Lisheng Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002393.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.4%.

What is its market cap?

As of today, the market cap is 5.31B.

Has Tianjin Lisheng Pharmaceutical Co., Ltd. ever had a stock split?

Tianjin Lisheng Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Apr 28, 2026.

Tianjin Lisheng Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Fujun Wang CEO
XSHE Exchange
CNE100000NJ9 ISIN
CN Country
1,604 Employees
28 Apr 2026 Last Dividend
28 Apr 2026 Last Split
23 Apr 2010 IPO Date

Overview

Tianjin Lisheng Pharmaceutical Co.,Ltd. is a prominent entity in China's pharmaceutical landscape, focusing on the research and development, production, and sales of a diverse range of pharmaceutical products. Established in 1951 and headquartered in Tianjin, China, the company has amassed extensive experience in the pharmaceutical industry, becoming a trusted name among healthcare professionals and patients alike. Operating as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd., Tianjin Lisheng Pharmaceutical has a wide-reaching impact in the medical field, significantly contributing to the well-being of individuals through its innovative healthcare solutions. Besides serving the domestic market, the company has made a mark on the international stage by exporting its products, showcasing its commitment to improving global health.

Products and Services

Tianjin Lisheng Pharmaceutical Co.,Ltd. offers an extensive portfolio of pharmaceutical products, catering to a broad spectrum of therapeutic fields. Each product form and category are designed to meet the varying needs of patients and healthcare providers. The company's product lineup includes:

  • Tablets, Soft Capsules, Granules, Flat Films, Pills, Mixtures, and Injections: These forms are available across a wide range of therapeutic areas, ensuring that the company can address a multitude of medical conditions effectively.
  • Nervous System: Products targeting the nervous system are developed to address conditions such as anxiety, depression, and neurological disorders, helping to improve the quality of life for affected individuals.
  • Musculoskeletal: This category includes treatments for musculoskeletal disorders, aiding in the relief of symptoms associated with conditions such as arthritis and osteoporosis.
  • Genitourinary System: Focused on the health of the urinary and reproductive systems, these products assist in treating infections, dysfunctions, and other related conditions.
  • Antineoplastic and Immune System: Offering treatments for cancer as well as drugs that support the immune system, these products play a critical role in managing and combating life-threatening diseases.
  • Sensory System: Products for the sensory system, including those for vision and hearing, contribute to the maintenance and improvement of sensory health.
  • Systemic Anti-Infection: These products are designed to combat a wide range of infections, supporting the body's ability to fight off disease-causing pathogens.
  • Respiratory System: Focusing on the health of the respiratory system, this category includes treatments for conditions such as asthma, COPD, and respiratory infections.
  • Endocrine System: Products targeting the endocrine system help in managing disorders related to hormone imbalances, such as diabetes and thyroid diseases.
  • Digestive System: Aimed at improving gastrointestinal health, these products address conditions like ulcers, GERD, and other digestive system disorders.
  • Cardiovascular System: Including a range of medications for heart and blood vessel conditions, these products support cardiovascular health, addressing issues such as hypertension and heart failure.
  • Drugs for Invigorating Qi and Blood: Reflecting the integration of traditional Chinese medicine principles, these products aim to enhance overall body strength and vitality.
  • Chinese and Western Tablets, Capsules, Oral Liquids, Granules, Biological Agents, and APIs: Tianjin Lisheng Pharmaceutical demonstrates its versatility and commitment to healthcare through the provision of both traditional Chinese medicine and Western pharmaceuticals, catering to the diverse preferences and needs of patients and healthcare providers globally.

Contact Information

Address: No.16, Saida North 1st Road, Tianjin, China, 300385
Phone: 86 22 2736 4241